Blockchain Registration Transaction Record

Cold Chain Biologic Labels Market to Triple by 2036

Cold chain biologic temperature monitoring labels market projected to grow from $60M in 2026 to $155M by 2036 at 10% CAGR, driven by biologics demand and regulatory compliance.

This news matters because it highlights a critical shift in how pharmaceutical supply chains ensure the safety and efficacy of temperature-sensitive biologic drugs. As vaccines, cell therapies, and specialty biologics become more common, the ability to instantly verify cold chain integrity at the product level directly impacts patient safety and reduces costly product losses. For healthcare providers and logistics firms, adopting these monitoring labels can streamline operations, enhance regulatory compliance, and build trust in the quality of biologic medicines delivered to patients.